−1.4525USD
−38.35 MUSD
20.20 M
About Galecto, Inc.
Sector
CEO
Hans Thalsgård Schambye
Headquarters
Boston
Website
Employees (FY)
13
Founded
2011
ISIN
US36322Q1076
FIGI
BBG00XMLGWC5
Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3, lysyl oxidase-like 2, and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GLTO is 0.7169 USD — it has decreased by 0.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Galecto, Inc. stocks are traded under the ticker GLTO.
Galecto, Inc. is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
GLTO stock is 5.73% volatile and has beta coefficient of 2.73. Check out the list of the most volatile stocks — is Galecto, Inc. there?
One year price forecast for Galecto, Inc. has a max estimate of 2.0000 USD and a min estimate of 2.0000 USD.
GLTO earnings for the last quarter are −0.30 USD per share, whereas the estimation was −0.34 USD resulting in a 11.76% surprise. The estimated earnings for the next quarter are −0.35 USD per share. See more details about Galecto, Inc. earnings.
Yes, you can track Galecto, Inc. financials in yearly and quarterly reports right on TradingView.
GLTO stock has risen by 0.24% compared to the previous week, the month change is a 6.91% fall, over the last year Galecto, Inc. has showed a 65.20% decrease.
GLTO net income for the last quarter is −6.48 M USD, while the quarter before that showed −8.14 M USD of net income which accounts for 20.42% change. Track more Galecto, Inc. financial stats to get the full picture.
Today Galecto, Inc. has the market capitalization of 19.52 M, it has decreased by 7.03% over the last week.
No, GLTO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GLTO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Galecto, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 13.00 employees. See our rating of the largest employees — is Galecto, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Galecto, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Galecto, Inc. stock shows the sell signal. See more of Galecto, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Galecto, Inc. future price: according to them, GLTO price has a max estimate of 2.00 USD and a min estimate of 2.00 USD. Read a more detailed Galecto, Inc. forecast: see what analysts think of Galecto, Inc. and suggest that you do with its stocks.